AKR1C3 is significantly upregulated in HCC and promotes tumor proliferation and metastasis through the activation of NF-κB signaling (Wu et al., 2022; Zhou et al., 2021). The gene discussed is AKR1C3; the disease is hepatocellular carcinoma.